Use of the Randox Evidence Investigator immunoassay system for near-body drug screening during post-mortem examination in 261 forensic cases
- Submitting institution
-
Abertay University
- Unit of assessment
- 12 - Engineering
- Output identifier
- 17656393
- Type
- D - Journal article
- DOI
-
10.1016/j.forsciint.2018.11.018
- Title of journal
- Forensic Science International
- Article number
- -
- First page
- 211
- Volume
- 294
- Issue
- -
- ISSN
- 0379-0738
- Open access status
- Compliant
- Month of publication
- November
- Year of publication
- 2018
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- Yes
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
3
- Research group(s)
-
B - Forensics
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- Forensic toxicology often involves investigations for cause of death. These can involve sampling for drug residue. However, drug concentration will vary within different areas in the body and will change with time after death, through post-mortem redistribution. Therefore specific sampling points are often indicated. However, blood (or other fluid) may not be available from putrefied or burnt bodies, and common techniques may not be suitable. This work uses an engineered biochip for rapid analysis of drug concentration in tissue, and assesses its reliability against gold-standard laboratory techniques, validating the methodologies to simplify and reduce the cost of death investigation procedures.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
